Myeloproliferative Neoplasm Animal Models

被引：28

作者：

Mullally, Ann ^{[1
]}

Lane, Steven W. ^{[2
]}

Brumme, Kristina ^{[1
]}

Ebert, Benjamin L. ^{[1
]}

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Div Hematol, Sch Med,Dept Med, Boston, MA 02115 USA

[2] Queensland Inst Med Res, Brisbane, Qld 4006, Australia

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2012年 / 26卷 / 05期

关键词：

Myeloproliferative neoplasms; Preclinical murine models; BCR-ABL; JAK2V617F; Hematopoietic stem cells; Bone marrow microenvironment; Myelofibrosis; Oncogenes; CHRONIC MYELOGENOUS LEUKEMIA; HEMATOPOIETIC STEM-CELLS; CHRONIC MYELOMONOCYTIC LEUKEMIA; MURINE MODEL; POLYCYTHEMIA-VERA; BONE-MARROW; MYELOID-LEUKEMIA; JAK2; INHIBITOR; CHRONIC-PHASE; MOUSE MODEL;

D O I：

10.1016/j.hoc.2012.07.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Myeloproliferative neoplasm (MPN) animal models accurately re-capitulate human disease in mice and have been an important tool for the study of MPN biology and therapy. Transplantation of BCR-ABL transduced bone marrow into irradiated syngeneic mice established the field of MPN animal modeling. Genetically engineered MPN animal models have enabled detailed characterization of the effects of specific MPN-associated genetic abnormalities on hematopoietic stem and progenitor cells (HSPCs). Xenograft models have allowed the study of primary human MPN-propagating cells in vivo. JAK2V617F, the most common molecular abnormality in BCR-ABL negative MPN, has been extensively studied using retroviral, transgenic, knock-in and xenograft models.

引用

页码：1065 / +

页数：19

共 88 条

[1] DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms [J].

Abdel-Wahab, O. ;

Pardanani, A. ;

Rampal, R. ;

Lasho, T. L. ;

Levine, R. L. ;

Tefferi, A. .

LEUKEMIA, 2011, 25 (07) :1219-1220

[2] Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms [J].

Abdel-Wahab, O. ;

Pardanani, A. ;

Patel, J. ;

Wadleigh, M. ;

Lasho, T. ;

Heguy, A. ;

Beran, M. ;

Gilliland, D. G. ;

Levine, R. L. ;

Tefferi, A. .

LEUKEMIA, 2011, 25 (07) :1200-1202

[3] Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies [J].

Abdel-Wahab, Omar ;

Mullally, Ann ;

Hedvat, Cyrus ;

Garcia-Manero, Guillermo ;

Patel, Jay ;

Wadleigh, Martha ;

Malinge, Sebastien ;

Yao, JinJuan ;

Kilpivaara, Outi ;

Bhat, Rukhmi ;

Huberman, Kety ;

Thomas, Sabrena ;

Dolgalev, Igor ;

Heguy, Adriana ;

Paietta, Elisabeth ;

Le Beau, Michelle M. ;

Beran, Miloslav ;

Tallman, Martin S. ;

Ebert, Benjamin L. ;

Kantarjian, Hagop M. ;

Stone, Richard M. ;

Gilliland, D. Gary ;

Crispino, John D. ;

Levine, Ross L. .

BLOOD, 2009, 114 (01) :144-147

[4] Efficacy of vorinostat in a murine model of polycythemia vera [J].

Akada, Hajime ;

Akada, Saeko ;

Gajra, Ajeet ;

Bair, Alicia ;

Graziano, Stephen ;

Hutchison, Robert E. ;

Mohi, Golam .

BLOOD, 2012, 119 (16) :3779-3789

[5] Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease [J].

Akada, Hajime ;

Yan, Dongqing ;

Zou, Haiying ;

Fiering, Steven ;

Hutchison, Robert E. ;

Mohi, M. Golam .

BLOOD, 2010, 115 (17) :3589-3597

[6] Link controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2 [J].

Bersenev, Alexey ;

Wu, Chao ;

Balcerek, Joanna ;

Tong, Wei .

JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (08) :2832-2844

[7] Lnk constrains myeloproliferative diseases in mice [J].

Bersenev, Alexey ;

Wu, Chao ;

Balcerek, Joanna ;

Jing, Jiang ;

Kundu, Mondira ;

Blobel, Gerd A. ;

Chikwava, Kudakwashe R. ;

Tong, Wei .

JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (06) :2058-2069

[8] Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder [J].

Braun, BS ;

Tuveson, DA ;

Kong, N ;

Le, DT ;

Kogan, SC ;

Rozmus, J ;

Le Beau, MM ;

Jacks, TE ;

Shannon, KM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :597-602

[9] Characterization of murine JAK2V617F-positive myeloproliferative disease [J].

Bumm, Thomas G. P. ;

Elsea, Collin ;

Corbin, Amie S. ;

Loriaux, Marc ;

Sherbenou, Daniel ;

Wood, Lisa ;

Deininger, Jutta ;

Silver, Richard T. ;

Druker, Brian J. ;

Deininger, Michael W. N. .

CANCER RESEARCH, 2006, 66 (23) :11156-11165

[10] Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO [J].

Chagraoui, C ;

Tulliez, M ;

Smayra, T ;

Komura, E ;

Giraudier, S ;

Yun, T ;

Lassau, N ;

Vainchenker, W ;

Wendling, F .

BLOOD, 2003, 101 (08) :2983-2989

← 1 2 3 4 5 6 7 8 9 →